ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
PDMR / PCA Dealing
Elixirr International plc (AIM: ELIX), an established, global award-winning challenger consultancy, announces that on 8 July 2022, the Company was notified that on that same day, the following PDMRs of the Company, and their PCAs, purchased ordinary shares of 0.005p in the Company ("Ordinary Shares"):
| Name | Position | Number of Ordinary Shares Purchased | Price Per Ordinary Share (p) | Resultant Number of Ordinary Shares | % of Issued Share Capital |
| Eric Rich | Partner and PDMR | 8,000 | 615 | 671,769 | 1.5% |
| Clare Filby | COO and PDMR | 5,690 | 615 | 533,798 | 1.2% |
| Nicholas Willott | Finance Director and PDMR | 3,249* | 615 | 274,073 | 0.6% |
* Purchase made by Claire Willott (spouse)
For further Information please contact:
| Elixirr International plc
Stephen Newton, CEO
Graham Busby, CFO
|
| |
|
Public and Investor Relations contacts: Caroline Pitt
finnCap Ltd (Nominated Adviser & Sole Broker)
Christopher Raggett / Kate Bannatyne (Corporate Finance)
Alice Lane / Sunila De Silva (ECM)
|
investor-relations@elixirr.com
+44 (0)20 7220 0500 | |
|
| | |
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Eric Rich | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Partner and PDMR | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Elixirr International plc | ||||
| b) | LEI | 213800MKY7OHMVAKW681 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | ||||
| Identification code | GB00BLPHTX84 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information:
| 8,000 shares at 615p
| ||||
| e) | Date of the transaction | 8 July 2022 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Clare Filby | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | COO and PDMR | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Elixirr International plc | ||||
| b) | LEI | 213800MKY7OHMVAKW681 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | ||||
| Identification code | GB00BLPHTX84 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information:
| 5,690 shares at 615p
| ||||
| e) | Date of the transaction | 8 July 2022 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Claire Willott | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | PCA to Finance Director and PDMR, Nicholas Willott | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Elixirr International plc | ||||
| b) | LEI | 213800MKY7OHMVAKW681 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | ||||
| Identification code | GB00BLPHTX84 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information:
| 3,249 shares at 615p
| ||||
| e) | Date of the transaction | 8 July 2022 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.